- Home
- SER vs KRON Comparison
SER vs KRON Comparison
Compare SER & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- KRON
- Stock Information
- Founded
- SER 2017
- KRON 2017
- Country
- SER United States
- KRON United States
- Employees
- SER N/A
- KRON 8
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- KRON Medicinal Chemicals and Botanical Products
- Sector
- SER Health Care
- KRON Health Care
- Exchange
- SER Nasdaq
- KRON Nasdaq
- Market Cap
- SER 56.5M
- KRON 54.1M
- IPO Year
- SER 2018
- KRON 2020
- Fundamental
- Price
- SER $5.80
- KRON $0.88
- Analyst Decision
- SER Strong Buy
- KRON Buy
- Analyst Count
- SER 1
- KRON 3
- Target Price
- SER $11.00
- KRON $1.63
- AVG Volume (30 Days)
- SER 16.6K
- KRON 1.4M
- Earning Date
- SER 08-08-2025
- KRON 08-07-2025
- Dividend Yield
- SER N/A
- KRON N/A
- EPS Growth
- SER N/A
- KRON N/A
- EPS
- SER N/A
- KRON N/A
- Revenue
- SER $51,000.00
- KRON $9,192,000.00
- Revenue This Year
- SER N/A
- KRON N/A
- Revenue Next Year
- SER N/A
- KRON N/A
- P/E Ratio
- SER N/A
- KRON N/A
- Revenue Growth
- SER N/A
- KRON 21.16
- 52 Week Low
- SER $3.81
- KRON $0.65
- 52 Week High
- SER $11.57
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- SER 57.53
- KRON 65.76
- Support Level
- SER $5.50
- KRON $0.87
- Resistance Level
- SER $6.29
- KRON $0.90
- Average True Range (ATR)
- SER 0.52
- KRON 0.01
- MACD
- SER 0.03
- KRON -0.00
- Stochastic Oscillator
- SER 74.44
- KRON 39.57
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.